pehub.com -- PDC Biotech GmbH, a Vienna, Austria-based women’s health drug startup whose first product focuses on preterm labor and primary dysmenorrhea, has raised over €4 million in Series A funding. MIG Verwaltungs AG and Edmond de Rothschild Investment Partners co-led the round.
